(ATE) Alten - Ratings and Ratios
Engineering, Consultancy, Technology
Dividends
| Dividend Yield | 2.07% |
| Yield on Cost 5y | 1.80% |
| Yield CAGR 5y | 14.47% |
| Payout Consistency | 84.5% |
| Payout Ratio | 35.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.7% |
| Value at Risk 5%th | 54.3% |
| Relative Tail Risk | -4.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -9.27 |
| CAGR/Max DD | -0.27 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.376 |
| Beta | 0.251 |
| Beta Downside | 0.515 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.10% |
| Mean DD | 30.97% |
| Median DD | 31.53% |
Description: ATE Alten November 09, 2025
Alten S.A. (ticker ATE) is a French-headquartered engineering and technology consultancy that delivers a broad portfolio of services-including mechanical and materials engineering, systems engineering, project-management office support, quality assurance, and a full suite of IT offerings such as cybersecurity, AI, cloud infrastructure, and embedded software-to corporate, telecom, and public-sector clients across Europe, North America, and the Asia-Pacific.
The firm’s client base spans high-tech and regulated industries: aeronautics, space, defense, automotive, rail, energy, life sciences, finance, telecoms, retail, media, and government services, reflecting a diversified revenue mix that reduces exposure to any single sector’s cyclicality.
Recent data (FY 2023) show Alten generated €3.6 billion in revenue, with an EBITDA margin of roughly 9 %, and a year-over-year organic growth rate of 5 % driven largely by rising demand for digital transformation and AI-enabled engineering solutions. The company’s R&D intensity-approximately 4 % of revenue-positions it to capture upside from the accelerating adoption of green-IT and Industry 4.0 initiatives, which the European Commission projects will grow at a CAGR of 7 % through 2028.
For a deeper, data-rich perspective on Alten’s valuation dynamics and peer comparisons, you might explore the analyst dashboards on ValueRay, which aggregate real-time financial metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (391.1m TTM) > 0 and > 6% of Revenue (6% = 494.9m TTM) |
| FCFTA 0.21 (>2.0%) and ΔFCFTA 15.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.62% (prev 18.54%; Δ -10.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 775.9m > Net Income 391.1m (YES >=105%, WARN >=100%) |
| Net Debt (35.8m) to EBITDA (849.3m) ratio: 0.04 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (35.1m) change vs 12m ago 0.85% (target <= -2.0% for YES) |
| Gross Margin 16.01% (prev 9.64%; Δ 6.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 234.2% (prev 116.7%; Δ 117.5pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 25.27 (EBITDA TTM 849.3m / Interest Expense TTM 25.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.12
| (A) 0.17 = (Total Current Assets 1.78b - Total Current Liabilities 1.15b) / Total Assets 3.61b |
| (B) 0.02 = Retained Earnings (Balance) 82.6m / Total Assets 3.61b |
| (C) 0.19 = EBIT TTM 655.1m / Avg Total Assets 3.52b |
| (D) 1.57 = Book Value of Equity 2.23b / Total Liabilities 1.42b |
| Total Rating: 4.12 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.41
| 1. Piotroski 7.50pt |
| 2. FCF Yield 30.98% |
| 3. FCF Margin 9.01% |
| 4. Debt/Equity 0.14 |
| 5. Debt/Ebitda 0.04 |
| 6. ROIC - WACC (= 13.89)% |
| 7. RoE 18.26% |
| 8. Rev. Trend 92.31% |
| 9. EPS Trend -25.53% |
What is the price of ATE shares?
Over the past week, the price has changed by +4.31%, over one month by +3.79%, over three months by +10.51% and over the past year by -4.07%.
Is ATE a buy, sell or hold?
What are the forecasts/targets for the ATE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.1 | 33.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 69.6 | -4% |
ATE Fundamental Data Overview December 12, 2025
Market Cap EUR = 2.36b (2.36b EUR * 1.0 EUR.EUR)
P/E Trailing = 15.8042
P/E Forward = 9.542
P/S = 0.5739
P/B = 1.0963
Beta = 1.157
Revenue TTM = 8.25b EUR
EBIT TTM = 655.1m EUR
EBITDA TTM = 849.3m EUR
Long Term Debt = 6.99m EUR (from longTermDebt, last quarter)
Short Term Debt = 134.9m EUR (from shortTermDebt, last quarter)
Debt = 312.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.40b EUR (2.36b + Debt 312.7m - CCE 276.9m)
Interest Coverage Ratio = 25.27 (Ebit TTM 655.1m / Interest Expense TTM 25.9m)
FCF Yield = 30.98% (FCF TTM 743.6m / Enterprise Value 2.40b)
FCF Margin = 9.01% (FCF TTM 743.6m / Revenue TTM 8.25b)
Net Margin = 4.74% (Net Income TTM 391.1m / Revenue TTM 8.25b)
Gross Margin = 16.01% ((Revenue TTM 8.25b - Cost of Revenue TTM 6.93b) / Revenue TTM)
Gross Margin QoQ = 7.02% (prev 18.67%)
Tobins Q-Ratio = 0.66 (Enterprise Value 2.40b / Total Assets 3.61b)
Interest Expense / Debt = 1.49% (Interest Expense 4.67m / Debt 312.7m)
Taxrate = 31.01% (37.1m / 119.7m)
NOPAT = 451.9m (EBIT 655.1m * (1 - 31.01%))
Current Ratio = 1.54 (Total Current Assets 1.78b / Total Current Liabilities 1.15b)
Debt / Equity = 0.14 (Debt 312.7m / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 0.04 (Net Debt 35.8m / EBITDA 849.3m)
Debt / FCF = 0.05 (Net Debt 35.8m / FCF TTM 743.6m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.83% (Net Income 391.1m / Total Assets 3.61b)
RoE = 18.26% (Net Income TTM 391.1m / Total Stockholder Equity 2.14b)
RoCE = 30.49% (EBIT 655.1m / Capital Employed (Equity 2.14b + L.T.Debt 6.99m))
RoIC = 20.14% (NOPAT 451.9m / Invested Capital 2.24b)
WACC = 6.25% (E(2.36b)/V(2.68b) * Re(6.94%) + D(312.7m)/V(2.68b) * Rd(1.49%) * (1-Tc(0.31)))
Discount Rate = 6.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.05%
[DCF Debug] Terminal Value 78.89% ; FCFE base≈522.8m ; Y1≈545.2m ; Y5≈629.1m
Fair Price DCF = 316.7 (DCF Value 11.04b / Shares Outstanding 34.9m; 5y FCF grow 4.55% → 3.0% )
EPS Correlation: -25.53 | EPS CAGR: -34.00% | SUE: 0.0 | # QB: 0
Revenue Correlation: 92.31 | Revenue CAGR: 33.30% | SUE: 0.73 | # QB: 0
EPS next Year (2026-12-31): EPS=7.28 | Chg30d=-0.255 | Revisions Net=+1 | Growth EPS=+12.9% | Growth Revenue=+1.9%